Gibraltar Biological Laboratories Incorporated – Trademark Portfolio

Entity Type: 03

Gibraltar Biological Laboratories Incorporated holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. The owner is based in Fairfield, NJ.

23 Just Rd.

Fairfield, NJ 07006

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Gibraltar Biological Laboratories Incorporated's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Gibraltar Biological Laboratories Incorporated have?

Gibraltar Biological Laboratories Incorporated has 6 U.S. trademarks filed with the USPTO.

What trademark classes does Gibraltar Biological Laboratories Incorporated file in?

Gibraltar Biological Laboratories Incorporated files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Gibraltar Biological Laboratories Incorporated's trademark registration success rate?

Gibraltar Biological Laboratories Incorporated has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.